WHO trial finds no benefit of 4 drugs for hospital COVID patients

Patient in ICU bed
Dec 03, 2020

Neither remdesivir, hydroxychloroquine, lopinavir, nor interferon-beta-1a—prevented death or other serious outcomes. 

Mary Van Beusekom | News Writer | CIDRAP News

Dec 03, 2020
Neither remdesivir, hydroxychloroquine, lopinavir, nor interferon-beta-1a—prevented death or other serious outcomes. Read More

Leave a Reply

Your email address will not be published.